The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
Saved in:
| Main Authors: | , , |
|---|---|
| Other Authors: | , , , , , , , , , , , , |
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2013
|
| In: |
Annals of oncology
Year: 2013, Volume: 24, Issue: 3, Pages: 618-624 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mds512 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/annonc/mds512 Verlag, Abstract, Volltext: http://annonc.oxfordjournals.org/content/24/3/618.abstract |
| Author Notes: | W. Eiermann, M. Rezai, S. Kümmel, T. Kühn, M. Warm, K. Friedrichs, A. Schneeweiss, S. Markmann, H. Eggemann, J. Hilfrich, C. Jackisch, I. Witzel, H. Eidtmann, A. Bachinger, S. Hell & J. Blohmer |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mds512 |